The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Vaccine Année : 2005

The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.

Résumé

Cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli belongs to a family of factors activating Rho GTPases. We report the in vivo effects of CNF1 in mice co-fed toxin and the soluble protein antigen ovalbumin (OVA). Similar to cholera toxin, CNF1 elicits adjuvanticity anti-OVA responses, both systemic and mucosal. In contrast, the catalytic inactive mutant CNF1-C866S demonstrated no effects. Using dermonecrotic toxin (DNT), a closely related Rho activating toxin from Bordetella, we discovered that the adjuvant property is within the DNT catalytic domain. Manipulation of Rho proteins thus provides a possible new approach for the development of effective mucosal immunoadjuvants.

Dates et versions

inserm-00000099 , version 1 (03-04-2006)

Identifiants

Citer

Patrick Munro, Gilles Flatau, Fabienne Anjuere, Véronique Hofman, Cecil Czerkinsky, et al.. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.. Vaccine, 2005, 23, pp.2551-6. ⟨10.1016/j.vaccine.2004.11.042⟩. ⟨inserm-00000099⟩
39 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More